​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $109.50, with a high of $117.00 and a low of $100.00. This represents a 36.67% increase from the last price of $80.12.

$45 $60 $75 $90 $105 $120 High: $117 Avg: $109.5 Low: $100 Last Closed Price: $80.12

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 27 Buy (75.00%), 8 Hold (22.22%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 8 27 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical36.67%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks28.49%

Price Target Trends

1M3M12M
# Anlaysts1312
Avg Price Target$100.00$106.67$103.42
Last Closing Price$80.12$80.12$80.12
Upside/Downside24.81%33.14%29.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26364--13
May, 26464--14
Apr, 26464--14
Mar, 26564--15
Feb, 26564--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 15, 2026Piper Sandler$100.00$80.3924.39%24.81%
May 08, 2026Needham$117.00$78.7748.53%46.03%
May 08, 2026Larry BiegelsenWells Fargo$103.00$85.0821.06%28.56%
Feb 25, 2026Richard NewitterTruist Financial$115.00$94.3221.93%43.53%
Jan 30, 2026Needham$112.00$90.2224.14%39.79%
Jan 26, 2026Cowen & Co.$110.00$92.9818.31%37.29%
Jan 09, 2026Canaccord Genuity$112.00$94.6218.37%39.79%
Jan 08, 2026Matt O'BrienPiper Sandler$115.00$90.5427.02%43.53%
Dec 17, 2025Shagun SinghRBC Capital$100.00$85.7916.56%24.81%
Dec 17, 2025Caitlin CroninCanaccord Genuity$105.00$85.7922.39%31.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 09, 2026Piper SandlerOverweightOverweighthold
May 08, 2026NeedhamBuyBuyhold
May 08, 2026Wells FargoOverweightOverweighthold
Jan 30, 2026NeedhamHoldBuyupgrade
Jan 26, 2026Cowen & Co.Buyinitialise
Jan 08, 2026Piper SandlerOverweightOverweighthold
Jan 08, 2026CitigroupMarket PerformMarket Performhold
Dec 30, 2025BTIGNeutralNeutralhold
Dec 17, 2025RBC CapitalOutperformOutperformhold
Dec 02, 2025Morgan StanleyOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.48$1.89$1.09$0.76$3.98---
Avg Forecast$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Low Forecast$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Surprise %-26.73%-6.90%-52.81%-74.58%16.03%---

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$958.10M$1.02B$1.57B$2.52B$2.94B---
Avg Forecast$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Low Forecast$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Surprise %0.65%-0.20%0.59%0.51%10.01%---

Net Income Forecast

$50M $160M $270M $380M $490M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$149.19M$190.17M$122.87M$102.98M$537.87M---
Avg Forecast$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Low Forecast$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Surprise %25.61%21.85%--69.66%38.01%---

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 27 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 36 Wall Street analysts, averages $109.5 over the next 12 months. The price target range spans from $100 at the low end to $117 at the high end, suggesting a potential 36.67% change from the previous closing price of $80.12.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a 36.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (28.49%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • June 2026: 23.08% Strong Buy, 46.15% Buy, 30.77% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 28.57% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 28.57% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $3.93, marking a -1.26% decrease from the reported $3.98 in 2025. Estimates for the following years are $4.62 in 2027, and $4.89 in 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a -2.99% decrease from the reported $2.94B in 2025. The forecast for 2027 is $3.06B, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

Globus Medical's net income forecast for the fiscal year ending in December 2026 stands at $466.32M, representing a -13.30% decrease from the reported $537.87M in 2025. Projections indicate $529.89M in 2027, and $560.54M in 2028.